PIPELINE

Candidate Indication Development status
  • Research
  • Lead Optimization
  • In Vitro
  • In Vivo
  • Phase Ⅰ
  • Phase Ⅱ
  • Phase Ⅲ
  • NDA
  • Commercialization
Neuro-Degenerative Disorder GXC-101 Alzheimer´s disease
In Vivo

Rare Genetic Disease GXC-301 Lafora disease
In Vivo
RPDD granted by US FDA

GXC-302 Undisclosed
In Vitro

GXC-303 ALS
In Vitro

GXC-304 Fronto Temporal Dementia
In Vivo

좌우로 스크롤 하시면 전체 내용을 확인할 수 있습니다.